Optimal adaptive nonpharmaceutical interventions to mitigate the outbreak of respiratory infections following the COVID-19 pandemic: a deep reinforcement learning study in Hong Kong, China

被引:2
|
作者
Yao, Yao [1 ]
Zhou, Hanchu [1 ]
Cao, Zhidong [2 ]
Zeng, Daniel Dajun [2 ]
Zhang, Qingpeng [3 ,4 ,5 ]
机构
[1] City Univ Hong Kong, Sch Data Sci, Hong Kong, Peoples R China
[2] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China
[3] Univ Hong Kong, Musketeers Fdn Inst Data Sci, Hong Kong, Peoples R China
[4] Univ Hong Kong, LKS Fac Med, Dept Pharmacol & Pharm, Hong Kong, Peoples R China
[5] Univ Hong Kong, Musketeers Fdn Inst Data Sci, LKS Fac Med, Dept Pharmacol & Pharm, Hong Kong, Peoples R China
关键词
Covid-19; reinforcement learning; artificial intelligence; machine learning; mathematical modelling; infectious diseases;
D O I
10.1093/jamia/ocad116
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Background Long-lasting nonpharmaceutical interventions (NPIs) suppressed the infection of COVID-19 but came at a substantial economic cost and the elevated risk of the outbreak of respiratory infectious diseases (RIDs) following the pandemic. Policymakers need data-driven evidence to guide the relaxation with adaptive NPIs that consider the risk of both COVID-19 and other RIDs outbreaks, as well as the available healthcare resources. Methods Combining the COVID-19 data of the sixth wave in Hong Kong between May 31, 2022 and August 28, 2022, 6-year epidemic data of other RIDs (2014-2019), and the healthcare resources data, we constructed compartment models to predict the epidemic curves of RIDs after the COVID-19-targeted NPIs. A deep reinforcement learning (DRL) model was developed to learn the optimal adaptive NPIs strategies to mitigate the outbreak of RIDs after COVID-19-targeted NPIs are lifted with minimal health and economic cost. The performance was validated by simulations of 1000 days starting August 29, 2022. We also extended the model to Beijing context. Findings Without any NPIs, Hong Kong experienced a major COVID-19 resurgence far exceeding the hospital bed capacity. Simulation results showed that the proposed DRL-based adaptive NPIs successfully suppressed the outbreak of COVID-19 and other RIDs to lower than capacity. DRL carefully controlled the epidemic curve to be close to the full capacity so that herd immunity can be reached in a relatively short period with minimal cost. DRL derived more stringent adaptive NPIs in Beijing. Interpretation DRL is a feasible method to identify the optimal adaptive NPIs that lead to minimal health and economic cost by facilitating gradual herd immunity of COVID-19 and mitigating the other RIDs outbreaks without overwhelming the hospitals. The insights can be extended to other countries/regions.
引用
收藏
页码:1543 / 1551
页数:9
相关论文
共 24 条
  • [1] Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong
    Chiu, Susan S.
    Cowling, Benjamin J.
    Peiris, J. S. Malik
    Chan, Eunice L. Y.
    Wong, Wilfred H. S.
    Lee, Kwok Piu
    EMERGING INFECTIOUS DISEASES, 2022, 28 (01) : 62 - 68
  • [2] Future trajectory of respiratory infections following the COVID-19 pandemic in Hong Kong
    Cheng, Weibin
    Zhou, Hanchu
    Ye, Yang
    Chen, Yifan
    Jing, Fengshi
    Cao, Zhidong
    Zeng, Daniel Dajun
    Zhang, Qingpeng
    CHAOS, 2023, 33 (01)
  • [3] Sustainable targeted interventions to mitigate the COVID-19 pandemic: A big data-driven modeling study in Hong Kong
    Zhou, Hanchu
    Zhang, Qingpeng
    Cao, Zhidong
    Huang, Helai
    Dajun Zeng, Daniel
    CHAOS, 2021, 31 (10)
  • [4] Impact of Nonpharmaceutical Interventions on the Incidence of Respiratory Infections During the Coronavirus Disease 2019 (COVID-19) Outbreak in Korea: A Nationwide Surveillance Study
    Huh, Kyungmin
    Jung, Jaehun
    Hong, Jinwook
    Kim, MinYoung
    Ahn, Jong Gyun
    Kim, Jong-Hun
    Kang, Ji-Man
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (07) : E184 - E191
  • [5] Online aviation learning experience during the COVID-19 pandemic in Hong Kong and Mainland China
    Ng, Davy Tsz Kit
    BRITISH JOURNAL OF EDUCATIONAL TECHNOLOGY, 2022, 53 (03) : 443 - 474
  • [6] Hospitalizations and mortality during the first year of the COVID-19 pandemic in Hong Kong, China: An observational study
    Xin, Hualei
    Wu, Peng
    Wong, Jessica Y.
    Cheung, Justin K.
    Lau, Eric H. Y.
    Leung, Gabriel M.
    Cowling, Benjamin J.
    Nealon, Joshua
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 30
  • [7] Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France
    Rybak, Alexis
    Levy, Corinne
    Angoulvant, Francois
    Auvrignon, Anne
    Gembara, Piotr
    Danis, Kostas
    Vaux, Sophie
    Levy-Bruhl, Daniel
    van der Werf, Sylvie
    Bechet, Stephane
    Bonacorsi, Stephane
    Assad, Zein
    Lazzati, Andrea
    Michel, Morgane
    Kaguelidou, Florentia
    Faye, Albert
    Cohen, Robert
    Varon, Emmanuelle
    Ouldali, Naim
    JAMA NETWORK OPEN, 2022, 5 (06) : E2218959
  • [8] The impact of multiple non-pharmaceutical interventions on controlling COVID-19 outbreak without lockdown in Hong Kong: A modelling study
    Yuan, Hsiang-Yu
    Blakemore, Colin
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2022, 20
  • [9] The impact of multiple non-pharmaceutical interventions on controlling COVID-19 outbreak without lockdown in Hong Kong: A modelling study
    Yuan, Hsiang-Yu
    Blakemore, Colin
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2022, 20
  • [10] Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis
    Leija-Martinez, Jose J.
    Esparza-Miranda, Luis A.
    Rivera-Alfaro, Gerardo
    Noyola, Daniel E.
    VIRUSES-BASEL, 2024, 16 (03):